St Jude Medical News

In this article, I analyze five relatively low-priced S&P stocks trading under $50 per share.

As 2012 gains momentum and business sentiment regarding the performance of the U.S. economy improves, now is the time to closely examine some large and mega-cap stocks that dominate their market sectors to determine if they are worthwhile investments.

Medtronic Inc. Wednesday released results from a study that it said showed patients with diseased blood vessels in the legs did not require additional treatment in the 12 months after being fitted with its Complete SE stent.

Boston Scientific Corporation A posted lower net income in the fourth quarter compared with a year-earlier period.

St. Jude Medical 's stock had its "positive" rating reaffirmed by research analysts at Canaccord Genuity in a report issued on Monday.

St. Jude Medical Inc., maker of devices to treat heart conditions, is betting on new technologies this year to overcome weak demand for older medical products, Chief Executive Officer Daniel Starks said.

The seemingly never-ending road to recovery just got a little longer for Boston Scientific .

Medical device maker Kensey Nash Corp posted better-than-expected quarterly profit, helped by growth in its core regenerative business that consists of orthopaedic and general surgery products.

Boston Scientific Corp . will unveil its latest earnings on Thursday, February 2, 2012.

Boston Scientific is scheduled to release its fourth quarter and fiscal 2011 earnings on Thursday, February 2, 2012, before the market opens.

Lawsuits by DuPont Co. and St. Jude Medical Inc. to protect trade secrets helped account for the largest increase in U.S. history last year in the size of intellectual-property jury awards.

If so, 2012 might see investors playing the same strategy so popular in 2011: Dividend stocks.

St. Jude Medical 's stock had its "neutral" rating reaffirmed by Zacks Investment Research in a research note issued on Monday.

S&P 500 component Boston Scientific Corp. will unveil its latest earnings on Thursday, February 2, 2012.

In a recent research report published by Morgan Keegan, St. Jude Medical, Inc.'s Riata lead is undergoing a FDA Class I recall because of an insulation issue.

The Board of Directors of the parent company of Kinetic Concepts, Inc. and LifeCell Corporation today announced that Ronald A. Matricaria has joined the Board of Directors and will serve as its Chairman.

In the realm of healthcare stocks too cheap to ignore, there are a lot of different stories to suit individual investor tastes.

Chicago, IL January 26, 2012 Zacks.com announces the list of stocks featured in the Analyst Blog.

St. Jude Medical was upgraded by research analysts at Canaccord Genuity from a "hold" rating to a "buy" rating in a report issued on Thursday.

Novartis - in an effort to settle a wage and hours class action lawsuit - decides to make a payment of up to $99 million to settle.